Hansa Biopharma AB Statistics
Total Valuation
STO:HNSA has a market cap or net worth of SEK 2.22 billion. The enterprise value is 2.77 billion.
Market Cap | 2.22B |
Enterprise Value | 2.77B |
Important Dates
The last earnings date was Thursday, July 17, 2025.
Earnings Date | Jul 17, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
STO:HNSA has 84.76 million shares outstanding. The number of shares has increased by 23.88% in one year.
Current Share Class | 84.76M |
Shares Outstanding | 84.76M |
Shares Change (YoY) | +23.88% |
Shares Change (QoQ) | +4.41% |
Owned by Insiders (%) | 6.63% |
Owned by Institutions (%) | 10.18% |
Float | 45.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.30 |
PB Ratio | -5.04 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.65 |
EV / Sales | 14.11 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37
Current Ratio | 1.37 |
Quick Ratio | 1.36 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.22 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -35.83% |
Return on Invested Capital (ROIC) | -54.78% |
Return on Capital Employed (ROCE) | -128.86% |
Revenue Per Employee | 1.40M |
Profits Per Employee | -4.26M |
Employee Count | 135 |
Asset Turnover | 0.21 |
Inventory Turnover | 25.16 |
Taxes
In the past 12 months, STO:HNSA has paid 4.14 million in taxes.
Income Tax | 4.14M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.38% in the last 52 weeks. The beta is 1.54, so STO:HNSA's price volatility has been higher than the market average.
Beta (5Y) | 1.54 |
52-Week Price Change | -34.38% |
50-Day Moving Average | 25.21 |
200-Day Moving Average | 28.89 |
Relative Strength Index (RSI) | 50.18 |
Average Volume (20 Days) | 353,227 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:HNSA had revenue of SEK 196.47 million and -596.68 million in losses. Loss per share was -8.72.
Revenue | 196.47M |
Gross Profit | 132.81M |
Operating Income | -535.04M |
Pretax Income | -592.54M |
Net Income | -596.68M |
EBITDA | -532.63M |
EBIT | -535.04M |
Loss Per Share | -8.72 |
Balance Sheet
The company has 354.42 million in cash and 906.21 million in debt, giving a net cash position of -551.79 million or -6.51 per share.
Cash & Cash Equivalents | 354.42M |
Total Debt | 906.21M |
Net Cash | -551.79M |
Net Cash Per Share | -6.51 |
Equity (Book Value) | -441.06M |
Book Value Per Share | -5.20 |
Working Capital | 156.84M |
Cash Flow
Operating Cash Flow | -560.18M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 67.60% |
Operating Margin | -272.33% |
Pretax Margin | -301.59% |
Profit Margin | n/a |
EBITDA Margin | -271.10% |
EBIT Margin | -272.33% |
FCF Margin | n/a |
Dividends & Yields
STO:HNSA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.88% |
Shareholder Yield | n/a |
Earnings Yield | -26.87% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |